Results 51 to 60 of about 17,623 (223)

Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus [PDF]

, 2013
© 2013 S. Karger AG, Basel.Background: A high prevalence of hyperandrogenism has been reported in women with type 1 diabetes (T1D). Metformin has been used as a therapeutic agent in patients with polycystic ovarian syndrome and in T1D patients without ...
Cassorla Goluboff, Fernando, López, Patricia, Codner Dujovne, Ethel, Torrealba, Isabel, Iñíguez Vila, Germán, Asenjo, Sylvia, Mujica, Verónica, Eyzaguirre, Francisca C.   +7 more
core   +1 more source

Hirsutism, Acne, and Hair Loss: Management of Hyperandrogenic Cutaneous Manifestations of Polycystic Ovary Syndrome

Gynecology Obstetrics & Reproductive Medicine, 2017
PPolycystic ovary syndrome is the most common endocrine abnormality that affects reproductive-aged women. Diagnostic criteria of polycystic ovary syndrome have been established by different societies in recent years, and hyperandrogenism remains as one ...
Cenk Yasa, Özlem Dural, Ercan Bastu, Funda Güngör Uğurlucan   +3 more
doaj   +1 more source

Endocrine and metabolic interactions in healthy pregnancies and hyperinsulinemic pregnancies affected by polycystic ovary syndrome, diabetes and obesity

Frontiers in Endocrinology, 2023
During pregnancy, the fetoplacental unit is key in the pronounced physiological endocrine changes which support pregnancy, fetal development and survival, birth and lactation. In healthy women, pregnancy is characterized by changes in insulin sensitivity
Adriana C. H. Neven, Aya Mousa, Jacqueline A. Boyle, Jacqueline A. Boyle, Helena J. Teede   +4 more
doaj   +1 more source

Microbial and Metabolic Correlates of Endometrial Dysfunction in Polycystic Ovary Syndrome: A Translational Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective Women with polycystic ovary syndrome (PCOS) exhibit a substantially increased risk of miscarriage, yet the underlying mechanisms remain inadequately understood. This study aimed to investigate whether specific gut microbial dysbiosis and metabolic disturbance are associated with and may potentially contribute to endometrial ...
Mengyu Jing, Xi Chen, Meiyan Jiang, Huiya Fang, Xiaoming Zhu, Xuejing Jin, Yonghui Jiao, Ningning Hou, Weiwei Gong, Aixia Liu   +9 more
wiley   +1 more source

Variations of Steroid Hormone Metabolites in Serum and Urine in Polycystic Ovary Syndrome after Nafarelin Stimulation: Evidence for an Altered Corticoid Excretion. [PDF]

, 1995
To evaluate the clinical relevance of testing pituitary-ovarian responses in patients suffering from polycystic ovary syndrome (PCOS) with the GnRH agonist nafarelin, a 1.2-mg dose of nafarelin was given intranasally to 19 women with PCOS and 15 healthy ...
Roger, Müller, Burkhardt, Höss, Cornelia, Burkhardt Moller, Jacob, Karl, Thomas Strowitzki, Michael M. Weber, Kimmig, Rainer, Weber, Michael M., Engelhardt, Dieter, Luppa, Peter, A. Lob, Peter Luppa, Dieter Engelhardt, Karl Jacob, Cornelia H, Rainer Kimmig, Strowitzki, Thomas, Lobo, Rogerio A.   +18 more
core   +1 more source

Cardiometabolic Risk in First Degree Relatives of Women With Polycystic Ovary Syndrome (PCOS)

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Polycystic ovary syndrome (PCOS) is a common multisystem disorder with reproductive, cardiometabolic and psychological implications. Genetic factors play a role in the pathogenesis of PCOS. We sought to investigate the cardiometabolic health of first degree relatives (FDR) of women with PCOS.
Su Jen Chua, Xinyi Wu, Tahani Al Kindi, Bulent O. Yildiz, Aya Mousa, Loyal Pattuwage, Helena Teede, Anju E. Joham, Chau Thien Tay   +8 more
wiley   +1 more source

Hyperandrogenism in Female Athletes [PDF]

The Journal of Clinical Endocrinology & Metabolism, 2018
New regulations for eligibility of female athletes with hyperandrogenism are restricted to differences of sex development, normal response to testosterone, and middle distance track disciplines.
openaire   +2 more sources

An Interesting Cause of Hyperandrogenemic Hirsutism

Case Reports in Endocrinology, 2014
Mild clinical signs of hyperandrogenism such as hirsutism may appear during the menopausal transition as part of the normal aging process, but the development of frank virilization suggests a specific source of androgen excess.
Murat Atmaca, İsmet Seven, Rıfkı Üçler, Murat Alay, Veysi Barut, Yaren Dirik, Yasin Sezgin   +6 more
doaj   +1 more source

Markers of hyperandrogenism in South Asians with polycystic ovary syndrome

Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 2014
Background: Many clinical and biochemical criteria are used to assess hyperandrogenism in subjects with polycystic ovary syndrome (PCOS). Standard indicators used to confirm hyperandrogenism are based predominantly on western data.
WMM Boteju, GDKN Karunarathna, SAD Udayangani, KGH Silva, CN Wijeyaratne   +4 more
doaj   +1 more source

Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome: A randomized, placebo‐controlled clinical trial

Health Science Reports, 2023
Background and Aims Polycystic ovary syndrome (PCOS) is one of the common endocrine disorders in women, which causes numerous symptoms in women. The relationship of many micronutrients with this syndrome has been investigated. This study was conducted to
Mahsa Gholizadeh‐Moghaddam, Hatav Ghasemi‐Tehrani, Gholamreza Askari, Mahsima Jaripur, Cain C. T. Clark, Mohammad Hossein Rouhani   +5 more
doaj   +1 more source